ASTRAZENECA DL-,25 SP.ADR
[WKN: 886715 | ISIN: US0463531089]
Aktienkurse
61,750€ 0,82%
Echtzeit-Aktienkurs ASTRAZENECA DL-,25 SP.ADR
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

Update on Imfinzi PEARL trial

19 December 2022 07:05 GMT Update on PEARL Phase III trial of Imfinzi monotherapy in Stage IV non-small cell lung cancer The PEARL Phase III…

Update on US review of Lynparza PROpel sNDA

15 December 2022 07:00 GMT Update on US regulatory priority review of Lynparza in combination with abiraterone in metastatic castration-resistant prostate cancer AstraZeneca and MSD today…

Total Voting Rights

1 December 2022 15:00 GMT Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

AstraZeneca announces sale of West Chester site

30 November 2022 07:05 GMT AstraZeneca announces sale of its West Chester, Ohio (US) manufacturing site National Resilience, Inc. to expand site and support…